Found: 38
Select item for more details and to access through your institution.
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Report
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 3, p. 409, doi. 10.1007/s10549-023-07030-x
- By:
- Publication type:
- Article
Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 265, doi. 10.1007/s10549-023-07015-w
- By:
- Publication type:
- Article
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 217, doi. 10.1007/s10637-020-00991-6
- By:
- Publication type:
- Article
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 791, doi. 10.1007/s10637-017-0486-4
- By:
- Publication type:
- Article
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 899, doi. 10.1007/s10147-023-02461-4
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
- By:
- Publication type:
- Article
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
- By:
- Publication type:
- Article
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 681, doi. 10.1007/s10147-024-02504-4
- By:
- Publication type:
- Article
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 700, doi. 10.1007/s10147-024-02541-z
- By:
- Publication type:
- Article
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 689, doi. 10.1007/s10147-024-02502-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 559, doi. 10.1007/s10147-024-02501-7
- By:
- Publication type:
- Article
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 551, doi. 10.1007/s10147-024-02499-y
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 545, doi. 10.1007/s10147-024-02491-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 355, doi. 10.1007/s10147-024-02469-4
- By:
- Publication type:
- Article
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 9, p. 1093, doi. 10.3390/biom14091093
- By:
- Publication type:
- Article
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1062, doi. 10.3390/cancers16051062
- By:
- Publication type:
- Article
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2632, doi. 10.3390/cancers15092632
- By:
- Publication type:
- Article
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399
- By:
- Publication type:
- Article
Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 454, doi. 10.1159/000345624
- By:
- Publication type:
- Article
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer.
- Published in:
- Oncology Letters, 2024, v. 27, n. 6, p. N.PAG, doi. 10.3892/ol.2024.14383
- By:
- Publication type:
- Article
Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study.
- Published in:
- Oncology Letters, 2023, v. 26, n. 5, p. 1, doi. 10.3892/ol.2023.14063
- By:
- Publication type:
- Article
Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 5, p. N.PAG, doi. 10.3892/mco.2021.2258
- By:
- Publication type:
- Article
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
- By:
- Publication type:
- Article
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 4, p. 621, doi. 10.1007/s12282-024-01575-5
- By:
- Publication type:
- Article
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 3, p. 765, doi. 10.1007/s12282-020-01200-1
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
- By:
- Publication type:
- Article
Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 3, p. 334, doi. 10.1007/s12282-019-01039-1
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 229, doi. 10.1007/s12282-018-0918-9
- By:
- Publication type:
- Article
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
- By:
- Publication type:
- Article
Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2017, v. 24, n. 1, p. 147, doi. 10.1007/s12282-016-0686-3
- By:
- Publication type:
- Article
Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2014, v. 21, n. 5, p. 550, doi. 10.1007/s12282-012-0426-2
- By:
- Publication type:
- Article